Johnson & Johnson TB drug patent renewal rejected in India
Johnson & Johnson TB drug patent renewal rejected in India Recently, India rejected Johnson & Johnson’s (J&J) attempt to increase its monopoly on a life-saving TB drug. More recently, Johnson & Johnson attempted to ‘evergreen’